Transient EZH2 suppression by Tazemetostat during in vitro expansion maintains T cell stemness and improves adoptive T cell therapy https://www.biorxiv.org/content/10.1101/2023.02.07.527459v1?med=mas
Transient EZH2 suppression by Tazemetostat during in vitro expansion maintains T cell stemness and improves adoptive T cell therapy https://www.biorxiv.org/content/10.1101/2023.02.07.527459v1?med=mas